EFFECTS OF D2-DOPAMINERGIC RECEPTOR STIMULATION ON MALE-RAT SEXUAL-BEHAVIOR

被引:87
作者
FOREMAN, MM
HALL, JL
机构
关键词
D O I
10.1007/BF02098495
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:153 / 170
页数:18
相关论文
共 28 条
[1]   STIMULATING EFFECTS OF LISURIDE ON MASCULINE SEXUAL-BEHAVIOR OF RATS [J].
AHLENIUS, S ;
LARSSON, K ;
SVENSSON, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 64 (01) :47-51
[2]   APOMORPHINE AND HALOPERIDOL-INDUCED EFFECTS ON MALE-RAT SEXUAL-BEHAVIOR - NO EVIDENCE FOR ACTIONS DUE TO STIMULATION OF CENTRAL DOPAMINE AUTORECEPTORS [J].
AHLENIUS, S ;
LARSSON, K .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 21 (03) :463-466
[3]   EFFECTS OF PERGOLIDE AND BROMOCRIPTINE ON MALE-RAT SEXUAL-BEHAVIOR [J].
AHLENIUS, S ;
ENGEL, J ;
LARSSON, K ;
SVENSSON, L .
JOURNAL OF NEURAL TRANSMISSION, 1982, 54 (3-4) :165-170
[4]   AN ALTERNATIVE APPROACH TO DEVELOPING DOPAMINE-RECEPTOR AGONISTS WITH CENTRAL PRE-SYNAPTIC ACTIONS FOLLOWING ORAL-ADMINISTRATION - A COMPARISON BETWEEN APOMORPHINE, BROMOCRIPTINE, AND THE NOVEL COMPOUND RDS-127 (2-DI-N-PROPYLAMINO-4,7-DIMETHOXYINDANE) [J].
ARNERIC, SP ;
LONG, JP .
DRUG DEVELOPMENT RESEARCH, 1983, 3 (03) :221-231
[5]  
Baraldi M., 1975, RIV FARMACOL TER, V6, P361
[6]   ACTIVATION WITH (+/-)N-N-PROPYL-NOR-APOMORPHINE (NPA) OF THE MALE-RAT COPULATORY-BEHAVIOR [J].
BENASSIBENELLI, A ;
FERRARI, F .
EXPERIENTIA, 1979, 35 (05) :645-646
[7]  
BENASSIBENELLI A, 1979, ARCH INT PHARMACOD T, V242, P241
[8]   ELEVATION OF ACETYLCHOLINE LEVELS IN STRIATUM OF RAT-BRAIN BY LY163502, TRANS-(-)-5,5A,6,7,8,9A,10-OCTAHYDRO-6-PROPYLPYRIMIDO(4,5-G)QUINOLIN-2-AMINE DIHYDROCHLORIDE, A POTENT AND STEREOSPECIFIC DOPAMINE (D2) AGONIST [J].
BYMASTER, FP ;
REID, LR ;
NICHOLS, CL ;
KORNFELD, EC ;
WONG, DT .
LIFE SCIENCES, 1986, 38 (04) :317-322
[9]   TOLERANCE TO SOME BEHAVIORAL-EFFECTS OF LISURIDE, A DOPAMINE RECEPTOR AGONIST, AND REVERSE TOLERANCE TO OTHERS, AFTER REPEATED ADMINISTRATION [J].
CARRUBA, MO ;
RICCIARDI, S ;
CHIESARA, E ;
SPANO, PF ;
MANTEGAZZA, P .
NEUROPHARMACOLOGY, 1985, 24 (03) :199-206
[10]  
CLARK JT, 1983, PHARMACOL BIOCHEM BE, V19, P781, DOI 10.1016/0091-3057(83)90080-1